In the >40 years group, a higher proportion of non-cancer individuals was observed (n = 7), particularly among those with the MSH2 variant (n = 4), resulting in a cancer to non-cancer ratio of 3:7 (0.43). The gene discussed is MSH2; the disease is cancer.